Opportunities for the treatment of inflammation in cardiovascular disease

Author： Crossman David C  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.11, 2001-11, pp. : 1751-1763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Targeting Inflammation in Cardiovascular Disease)

By  

Medicinal Chemistry, Vol. 10, Iss. 7, 2014-11 ,pp. : 641-642

Bentham Science Publishers

Access to resources Recommend Favorite

Myeloperoxidase: Expressing Inflammation and Oxidative Stress in Cardiovascular Disease

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 2, 2013-01 ,pp. : 115-138

Bentham Science Publishers

Access to resources Recommend Favorite

Torcetrapib: promising in the treatment of cardiovascular disease

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Drug Treatment of Obesity in Cardiovascular Disease

By Charakida Marietta   Finer Nicholas  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 93-104

Adis International

Access to resources Recommend Favorite

Garlic for Cardiovascular Disease: Prevention or Treatment?

By  

Current Pharmaceutical Design, Vol. 23, Iss. 7, 2017-04 ,pp. : 1028-1041

Bentham Science Publishers

Access to resources Recommend Favorite